Style | Citing Format |
---|---|
MLA | Khosravi A, et al.. "Biological Evaluation of New Oxadiazole-Based Synthetic Α-Glycosidase Inhibitors for Hyperglycemia Management: A Research Study." Iranian Journal of Pharmaceutical Sciences, vol. 18, no. 1, 2022, pp. 65-75. |
APA | Khosravi A, Pirooznia N, Vaezi G, Hojati V, Abdi K (2022). Biological Evaluation of New Oxadiazole-Based Synthetic Α-Glycosidase Inhibitors for Hyperglycemia Management: A Research Study. Iranian Journal of Pharmaceutical Sciences, 18(1), 65-75. |
Chicago | Khosravi A, Pirooznia N, Vaezi G, Hojati V, Abdi K. "Biological Evaluation of New Oxadiazole-Based Synthetic Α-Glycosidase Inhibitors for Hyperglycemia Management: A Research Study." Iranian Journal of Pharmaceutical Sciences 18, no. 1 (2022): 65-75. |
Harvard | Khosravi A et al. (2022) 'Biological Evaluation of New Oxadiazole-Based Synthetic Α-Glycosidase Inhibitors for Hyperglycemia Management: A Research Study', Iranian Journal of Pharmaceutical Sciences, 18(1), pp. 65-75. |
Vancouver | Khosravi A, Pirooznia N, Vaezi G, Hojati V, Abdi K. Biological Evaluation of New Oxadiazole-Based Synthetic Α-Glycosidase Inhibitors for Hyperglycemia Management: A Research Study. Iranian Journal of Pharmaceutical Sciences. 2022;18(1):65-75. |
BibTex | @article{ author = {Khosravi A and Pirooznia N and Vaezi G and Hojati V and Abdi K}, title = {Biological Evaluation of New Oxadiazole-Based Synthetic Α-Glycosidase Inhibitors for Hyperglycemia Management: A Research Study}, journal = {Iranian Journal of Pharmaceutical Sciences}, volume = {18}, number = {1}, pages = {65-75}, year = {2022} } |
RIS | TY - JOUR AU - Khosravi A AU - Pirooznia N AU - Vaezi G AU - Hojati V AU - Abdi K TI - Biological Evaluation of New Oxadiazole-Based Synthetic Α-Glycosidase Inhibitors for Hyperglycemia Management: A Research Study JO - Iranian Journal of Pharmaceutical Sciences VL - 18 IS - 1 SP - 65 EP - 75 PY - 2022 ER - |